跳至主要内容
临床试验/ACTRN12616001504404
ACTRN12616001504404已完成未知

ongitudinal Study in Knee Osteoarthritis (OA) of Benchmarking Clinical Response and State-attainment following Viscosupplementation with SYNVISC-ONE (LOBRAS Study)

The University of Queensland0 个研究点目标入组 130 人开始时间: 2016年10月31日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
30 Years 至 90 Years(—)
性别
All

入选标准

  • a.Scheduled for SYNVISC ONE therapy.
  • bMale or female subjects, 30 to 90 years of age, inclusive.
  • c.Clinical history of symptomatic knee OA.
  • d.Radiographic evidence of knee OA. (Kellgren and Lawrence (K-L) Scale Grade I-III).
  • e.Fluent in English.
  • f.Willing and able to provide written informed consent.
  • g.Baseline pain score in study knee on a single VA global pain rating scale of between 35mm to 90mm (0-100mm scale).

排除标准

  • a.History of gout or episodes of pseudogout in the study joint.
  • b.History of rheumatoid arthritis or psoriatic arthritis.
  • c.Kellgren and Lawrence Grade IV OA radiographs.
  • d.Previous treatment with viscosupplementation in the last six months.
  • e.Contraindications to SYNVISC ONE treatment as outlined in the product monograph.

研究者

相似试验